Editorial: Multi-targeted tyrosine kinase inhibitors in the treatment of cancer and neurodegenerative disorders

• Belgin Sever,
• Belgin Sever,
• Luciano Saso,
• Rumiana Tzoneva,
• Valentina Onnis,
• Halilibrahim Ciftci,
• Halilibrahim Ciftci,
• Halilibrahim Ciftci

Affiliations

Belgin Sever

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskisehir, Türkiye

Belgin Sever

Medicinal and Biological Chemistry Science Farm Joint Research Laboratory, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan

Luciano Saso

Department of Physiology and Pharmacology “Vittorio Erspamer”, Sapienza University of Rome, Rome, Italy

Rumiana Tzoneva

Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Sofia, Bulgaria

Valentina Onnis

Department of Life and Environmental Sciences, University of Cagliari, Monserrato University Campus, Cagliari, Italy

Halilibrahim Ciftci

Medicinal and Biological Chemistry Science Farm Joint Research Laboratory, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan

Halilibrahim Ciftci

Department of Bioengineering Sciences, Izmir Katip Celebi University, Izmir, Türkiye

Halilibrahim Ciftci

Department of Drug Discovery, Science Farm Ltd., Kumamoto, Japan